Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.810
-0.075-1.54%
Volume:8.23M
Turnover:39.48M
Market Cap:30.22B
PE:6.41
High:4.930
Open:4.930
Low:4.755
Close:4.885
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.51
T/O Rate:0.13%
Dividend:0.22
Dividend Rate:4.53%
EPS(LYR):0.751
ROE:8.96%
ROA:2.91%
PB:0.50
PE(LYR):6.41
PS:0.10

Loading ...

CR Boya Bio-pharmaceutical Q1 2026: Revenue Down 40.1% YoY, Net Profit Drops 78.4%

Bulletin Express
·
Apr 24

China Resources Pharmaceutical - Cr Boya Bio-Pharmaceutical Qtrly Unaudited Revenue RMB 321.1 Mln, Net Profit RMB 30.0 Mln

THOMSON REUTERS
·
Apr 24

China Resources Pharma subsidiary CR Boya Bio Q1 net profit falls to RMB 30 million

Reuters
·
Apr 24

CHINARES PHARMA's Unit Kpc Pharmaceuticals Swings to Q1 Loss

Stock News
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Net Loss at RMB 144.8 Mln

THOMSON REUTERS
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Revenue at RMB 836.2 Mln

THOMSON REUTERS
·
Apr 24

CR Sanjiu Q1 2026: Revenue Jumps 18.6% but Net Profit Slips 9.1%; Cash Outflow Weighs on China Resources Pharmaceutical Subsidiary

Bulletin Express
·
Apr 24

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit For CR Jiangzhong RMB312.0 MLN

Reuters
·
Apr 24

CHINARES PHARMA Subsidiary Tasly Pharmaceutical Delivers 5.35% Revenue and 9.78% Profit Growth in Q1 2026

Bulletin Express
·
Apr 24

CR Pharma’s Dong-E-E-Jiao Posts 7.1% Profit Growth in Q1 2026, Cash Reserves Surge

Bulletin Express
·
Apr 24

CR Double-Crane Q1 2026 Revenue Down 8.84%, Net Profit Declines 4.08%; Majority-Owned by CR Pharma

Bulletin Express
·
Apr 24

CR Double-Crane Q1 net profit falls to RMB 501.38 million

Reuters
·
Apr 24

Dong-E-E-Jiao Q1 net profit rises to RMB 454.77 million

Reuters
·
Apr 24

China Resources Pharma's Dong-E-E-Jiao Reports Q1 Net Profit of 455 Million Yuan, Up 7.12%

Stock News
·
Apr 24

China Resources Pharmaceutical - China Resources Double-Crane Pharmaceutical Q1 Revenue RMB2.81 Bln

THOMSON REUTERS
·
Apr 24

CR Pharma Completes RMB1.50 Billion First-Tranche Issuance of 2026 Corporate Bonds at 1.65% Coupon

Bulletin Express
·
Apr 16

China Resources Pharma Subsidiary Concludes RMB 1.5 Billion Corporate Bond Issuance

Stock News
·
Apr 16

China Resources Pharma unit issues RMB 1.5 billion three-year bonds at 1.65%

Reuters
·
Apr 16

BrainAurora appoints Yang Fan, Wang Jingbo as non-executive directors

Reuters
·
Apr 15

DIARY-China corporate earnings week ahead

Reuters
·
Apr 03